InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,205.60
(
0.16%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.23
(
0.05%
)
Bitcoin
60,913.30
(
-1.45%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whosetosay

Send PM Follow Ignore
Followers 26
Posts 4429
Boards Moderated 0
Alias Born 06/08/2010

Whosetosay

Re: None

Friday, 09/13/2013 10:34:27 PM

Friday, September 13, 2013 10:34:27 PM

Post# of 80490
I can't recall what % of the naïve patients have the T315I mutation, but whatever that %, that number X 70% or so is Iclusig's headstart on the required 51%. Add a couple of more % for other mutations. Looking for the 53% and into the mid 50's for Iclusig's performance, in line with 2nd line performance.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up